10-Q: Upexi, Inc. Reports Q3 2025 Results, Revenue Declines Amid Strategic Shift

Upexi, Inc.'s Q3 2025 results show a revenue decline due to a strategic shift away from recommerce, despite improved gross profit margins.

Summary

• Upexi, Inc. reported a net loss of $3,831,660 for the three months ended March 31, 2025, compared to a net loss of $4,118,612 for the same period in 2024.
• Revenue decreased by 39% to $3,160,480, primarily due to a strategic shift away from the recommerce business.
• Gross profit margin increased to 49% from 24% in the same period last year.
• General and administrative expenses increased by 46% due to reserves for Amazon receivables and higher legal and auditing costs.
• The company had cash of $230,392 as of March 31, 2025, a decrease of $431,023 from June 30, 2024.
• For the nine months ended March 31, 2025, the company reported a net loss of $6,758,547 compared to a loss of $7,912,919 for the same period in 2024.
• Revenue for the nine months decreased by 45% to $11,522,487.
• The company completed a private placement offering on April 24, 2025, raising approximately $92.59 million.
• The company's financial reporting is organized into a single segment that includes production, sales and distribution of branded products, following the sale of E-Core, Technology Inc. and its subsidiaries.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While revenue declined, gross profit margins improved, and the company secured significant funding through a private placement. However, internal control weaknesses and ongoing losses remain concerns.

Positives

• Gross profit margin increased to 49% for the three months ended March 31, 2025, compared to 24% for the same period in 2024, indicating improved profitability on sales.
• Other operating expenses decreased by $703,466 or 60%, compared with the same period last year.
• Other expenses, which is primarily interest decreased by $1,023,112 or 136% compared with the same period last year.
• The company completed a private placement offering on April 24, 2025, raising approximately $92.59 million, strengthening its financial position.

Negatives

• Revenue decreased by 39% to $3,160,480 for the three months ended March 31, 2025, compared to $5,223,242 for the same period in 2024, primarily due to a strategic shift away from recommerce.
• General and administrative expenses increased by $828,028 or 46% compared with the same period last year.
• The company had cash of $230,392 as of March 31, 2025, a decrease of $431,023 from June 30, 2024.
• The company had a net loss of $3,831,660 for the three months ended March 31, 2025 compared to a loss of $4,118,612 for the same period in 2024.

Risks

• The company's strategic shift away from recommerce has resulted in a significant revenue decline.
• The company's internal controls over financial reporting were deemed ineffective due to inadequate segregation of duties and lack of multiple levels of supervision and review.
• The company's auditors and the audit committee of the registrants board of directors have been made aware of all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information.
• The company's auditors and the audit committee of the registrants board of directors have been made aware of any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.
• There is substantial uncertainty and different interpretations among federal, state and local regulatory agencies, legislators, academics and businesses as to the scope of operation of Farm Bill-compliant hemp programs relative to the emerging regulation of cannabinoids.

Future Outlook

Management expects the trend of improved gross profit margins to continue with the focus on sales of branded products. Management expects that general and administrative expenses to return to normal levels as the restructuring of the operations is significantly complete as of May 1, 2025 and reserves have been already been increased to reserve assets that may not be fully realized. We estimate that we will have sufficient working capital to fund our operations over the twelve months following the date of the issuance of these condensed consolidated financial statements and meet all of our debt obligations.

Management Comments

• Management has augmented the overall strategy of the Company to focus on product sales, including the development, production and distribution of branded products.
• Management expects the trend to continue with the focus on sales of branded products.
• Management will continue to reduce overall distribution costs with the consolidation of products and facilities.
• Management expects that general and administrative expenses to return to normal levels as the restructuring of the operations is significantly complete as of May 1, 2025 and reserves have been already been increased to reserve assets that may not be fully realized.

Industry Context

The shift away from recommerce and focus on branded products reflects a strategic realignment that may be influenced by broader industry trends favoring higher-margin, proprietary products over reselling commoditized goods. The company's focus on branded products aligns with a trend towards direct-to-consumer sales and building brand equity.

Comparison to Industry Standards

• It is difficult to compare Upexi's results directly to industry standards without knowing the specific segments in which its branded products compete.
• However, the increased gross profit margin suggests improved efficiency or pricing power in its chosen product categories.
• The company's strategic shift is similar to that of other companies that have moved away from low-margin reselling to focus on proprietary products and direct-to-consumer sales.

Legal Proceedings

• Get Fit Fast Supplements, LLC, filed a lawsuit against Cygnet Online, LLC, et al., including, but not limited to the Company and Eric Hanig.
• The case is presently in active arbitration and is styled Get Fit Fast Supplements, LLC v. Cygnet Online, LLC, et al., American Arbitration Association Case No. 01-24-0003-1085.
• The parties are seeking monetary damages in their various claims and counterclaims against one another.
• The Company is vigorously defending all claims made against it in the case.

Related Party Transactions

• In June 2024, Allan Marshall, the Companys CEO advanced the Company $100,000 to enable the Company to purchase equipment needed for the new warehouse facility.
• Subsequent to December 31, 2024, Mr. Marshall advanced the Company $400,000 to cover short term negative cash flow.
• In March 2025, Allan Marshall purchased 125,000 shares of Series A preferred shares from the Company at a per share price of $2.60 per preferred share.
• On April 1, 2024, the Company entered into a lease agreement with MFA 2510 Merchant LLC, which is owned by our CEO, Allan Marshall.
• On June 13, 2024, the Company entered into a Stock Purchase Agreement (SPA) pursuant to which the Company sold one hundred percent (100%) of the issued and outstanding equity (the Interests) of its wholly owned subsidiary VitaMedica, Inc. to three investors (the Buyers).
• One of the minority interest buyers is Allan Marshall, the Companys CEO.

Stakeholder Impact

• Shareholders: Dilution from stock issuance, potential for long-term growth with strategic shift.
• Employees: Potential job security with new funding, uncertainty during restructuring.
• Customers: Focus on branded products may lead to improved product quality and customer experience.
• Creditors: Improved ability to repay debts with new funding.

Next Steps

• The company plans to implement the appointment of additional qualified personnel to address inadequate segregation of duties and implement modifications to our financial controls to address such inadequacies, by the end of our 2025 fiscal year as resources allow.
• The company is currently reviewing our disclosure controls and procedures related to these material weaknesses and expect to implement changes in the current fiscal year, including identifying specific areas within our governance, accounting and financial reporting processes to add adequate resources to potentially mitigate these material weaknesses.

Key Dates

Keywords

revenue, net loss, gross profit, Upexi, financial results, Q3 2025, recommerce, private placement, operating expenses, financial statements